Latest raise
$5.3M
Date raised
November 10, 2026
Round
Pre-Seed
Websitewww.switchpointbio.com
About Samuel Myllykangas
They provide a blood-based epigenomic platform for drug developers to understand how disease and treatment affect human biology.
- Who is Samuel Myllykangas?
- Samuel Myllykangas is listed as Co-founder and CEO of Switchpoint Bio, a biotechnology company.
- How much did Switchpoint Bio raise?
- Switchpoint Bio raised $5.3M in a Pre-Seed round on November 10, 2026 (3 days ago).
Get newly funded founders every week
A free weekly list of startups that just raised.